Bcr1264-2.jpg (47.56 kB)
Pharmacokinetic parameters for individual patients on treatment day 5
figure
posted on 2011-12-30, 15:15 authored by Gunter von Minckwitz, Sebastian Harder, Sascha Hövelmann, Elke Jäger, Salah-Eddin Al-Batran, Sibylle Loibl, Akin Atmaca, Christian Cimpoiasu, Antje Neumann, Aklil Abera, Alexander Knuth, Manfred Kaufmann, Dirk Jäger, Alexander B Maurer, Winfried S WelsCopyright information:
Taken from "Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas"
Breast Cancer Research 2005;7(5):R617-R626.
Published online 1 Jun 2005
PMCID:PMC1242130.
Copyright © 2005 von Minckwitz et al, licensee BioMed Central Ltd.
Dose versus peak plasma concentration, . Dose versus area under the concentration–time curve (AUC).